Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20041
20052
20062
20074
20083
20104
20115
20123
20131
20143
20154
20161
20186
20192
20203
202110
20229
20238
20246
20251
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated20
Active, not recruiting15
Recruiting12
Unknown status8
Withdrawn6
Not yet recruiting3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
UCB Pharma6
AstraZeneca5
Novartis Pharmaceuticals5
GlaxoSmithKline4
Human Genome Sciences Inc., a GSK Company4
Viatris Innovation GmbH4
Anthera Pharmaceuticals3
Biogen3
Bristol-Myers Squibb3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic99
Autoimmune Diseases19
Lupus Nephritis14
Immune System Diseases11
Connective Tissue Diseases10
Nephritis6
Lupus Erythematosus, Cutaneous4
Lupus Erythematosus, Discoid3
Bone Diseases, Metabolic2
Glomerulonephritis2

Trials

Showing 51 to 75 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.